Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Drug
2.3. Procedure
2.4. Subjective Reports Evaluation
- Could you describe your experience with the substance used in the experiment?
- Do you think this experience has had an impact on your current alcohol consumption? What about your life quality?
- Was this experience important in your life?
- 3.1.
- How much?
- 3.2.
- Why?
- 3.3.
- Which aspects of the experience were more relevant to you?
2.5. Data Analysis
3. Results
3.1. Demographic
3.2. Categories
3.3. Subcategories
3.3.1. Self-Perception of Experience
Experience Uniqueness
“Well, the experience was unique. Before participating on the trial, I had tried other substances […] but, in my opinion, this (ayahuasca) was the only one capable of, during its maximal effect, make me lose… sense of reality”(V5).
“But, like, it was a unique experience, I had not guessed how one would behave during the session… If you would forget about using a substance, where you were, what you used, the other people in the room […] and you are conscious about what you used, you know, to be feeling this”(V6).
3.3.2. Positive Impacts
Anxiety Reduction
“I noticed that it helped with my anxiety, and I think it’s a psychological effect of keeping me in control, for example, I have the habit of biting my nails […] since the beginning of the protocol I have been basically 20 days without biting them”(V2).
“I am very anxious and until now my anxiety improved a lot. For example, I have an issue, usually I would be sitting here constantly shaking my legs. And I am still not doing this anymore”(V5).
Tranquility
“These last few days I […] had a lot of activities […] had tense obligations, like tests, and I believe that in other situations like these, that I have been through in the past, even recently, I did not feel as calm as I have been in the past few weeks […] my mood was so much better, I think I dealt with things very calmly, and my anxiety did not worsened” “I feel more willing after I used it (ayahuasca), like, I guess my tranquility is related to my willingness. I am calmer, I am more willing”(V1).
“It was, like, a mentality change. It feels like I calmed down a lot after the experience, so this was very, very good”(V4).
Therapeutic Effects Duration
“[…] and I believe that in other situations like these, that I have been through in the past, even recently, I did not feel as calm as I have been in the past few weeks, so it is very interesting, my mood was so much better […]. I feel more tolerant with situations”(V1).
“Effects that last a long time, I feel like I am in a lighter state, calmer, for at least 15 to 20 days”(V2).
Lightness
“I feel more at ease [...]. In the first days, I was even scared of becoming an esoteric boy […]”(V2).
“I left feeling very light and feeling well about my life. Generally speaking, it was very nice”(V3).
Shift in Mental Patterns
“But I already feel like the context changed, even if the context changed unconsciously, maybe this makes more sense”(V2).
“More comfortable with my choices and so, I felt more comfortable in general. I feel like this shift in mentality, bigger and calmer, was very important. Especially because of that, because I left with more positive thoughts, I was having very negative thoughts before. And it is not that I do not have them anymore, sometimes I feel very negative, but I feel more at ease. It was a very introspective experience, you know? Then I felt more comfortable with myself and prepared to begin a path to be more comfortable with myself […]”(V4)
3.3.3. Substance Use Pattern
Decrease in Alcohol Intake
“But I actually felt like sometimes I got more moderate […] before I used to drink almost every day, almost like a habit. I got home, opened a bottle, and drank; I opened I can and drank, I would drink a few routinely. In the last weeks it has become more like a social experience, during moments when I am with other people”(V2).
“My alcohol intake is decreasing, my tobacco use as well. I decided this, I am decreasing my use of drugs in general. I was already considering this, already thinking about this, but dependence is very hard, it is something that comes and go. But now my mentality is much more willing to this”(V4).
“My point was, like, drinking on weekends, right? Like, drinking a lot. So, in this first week, I also drank, right? You know, when I went out. But I drank less, not in an exaggerated way, compared to before”(V5).
Decrease in Tobacco Use
“My tobacco use decreased a lot”(V4).
“In this first week I decreased smoking a lot”(V5).
3.3.4. Insights
Significant
“I have got really thoughtful sometimes, it was really outstanding and will be forever engraved in my memory”(V1).
“Small insights that I have got, that arose during the experimental session, in some way will be taken with me for the rest of my life”(V2).
Life Choices Insights
“I reflected on my college degree, the place where I live and my relationship with my girlfriend”(V1).
“So, there is this reflection I had in the beginning, you know, during the peak of effects. I still cannot understand why, I cannot fully interpretate, but it is about the reason I practice so many sports. It looks like I am trying no to be a burden to anyone in the future”(V6).
Nonspecific
“But it was a pleasant experience, I had a few insights”(V3).
“During the substance effects, I have got these stories, these thoughts…”(V6)
3.3.5. Visual effects
Increased Visual Effects with Closed Eyes
“I just closed my eyes and even with my eyes closed I saw many imaging patterns, kind of psychedelic motifs, it looked like a kaleidoscopic […] when I opened my eyes there was a lot less patterns, the best part was keeping my eyes closed”(V3).
“So, my sight was normal, and my hearing as well, but when I closed my eyes, I began to have visions”(V4).
“When I closed my eyes, I went back to this trip, this religious experience”(V5).
“There was a lot of visual effects… They had specific formats, but they were mainly focused on the hospital bed… Later I saw abstract shapes and a lot of color”(V6).
3.3.6. Physical Symptoms
“I went to the bathroom, and I had diarrhea. I went to the bathroom several times…”(V4)
“I only know that at some point she (entity) asked me, something like, that in order to continue the purification process I would have to throw up… And I was embarrassed to throw up in here”(V5).
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- dos Santos, R.G.; Landeira-Fernandez, J.; Strassman, R.J.; Motta, V.; Cruz, A.P.M. Effects of ayahuasca on psychometrc measures of anxiety, panic-like and hopelessness in Santo Daime members. J. Ethnopharmacol. 2007, 112, 507–513. [Google Scholar] [CrossRef] [PubMed]
- dos Santos, R.G.; Balthazar, F.M.; Bouso, J.C.; Hallak, J.E.C. Current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J. Psychopharmacol. 2016, 30, 1230–1247. [Google Scholar] [CrossRef] [PubMed]
- dos Santos, R.G.; Osório, F.L.; Crippa, J.A.S.; Hallak, J.E.C. Antidepressive and anxiolytic effects of ayahuasca: A systematic literature review of animal and human studies. Braz. J. Psychiatry 2016, 38, 65–72. [Google Scholar] [CrossRef] [PubMed]
- Sanches, R.F.; Osório, F.L.; dos Santos, R.G.; Macedo, L.R.; Maia-de-Oliveira, J.P.; Wichert-Ana, L.; de Araujo, D.B.; Riba, J.; Crippa, L.A.S.; Hallak, J.E.C. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. J. Clin. Pharmacol. 2016, 36, 77–81. [Google Scholar] [CrossRef] [PubMed]
- Palhano-Fontes, F.; Barreto, D.; Onias, H.; Andrade, K.C.; Novaes, M.M.; Pessoa, J.A.; Mota-Rolim, S.A.; Osório, F.L.; Sanches, R.; Dos Santos, R.G.; et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychol. Med. 2019, 49, 655–663. [Google Scholar] [CrossRef] [PubMed]
- Grob, C.S.; McKenna, D.J.; Callaway, J.C.; Brito, G.S.; Neves, E.S.; Oberlaender, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; et al. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J. Nerv. Ment. Dis. 1996, 184, 86–94. [Google Scholar] [CrossRef] [PubMed]
- Barbosa, P.C.R.; Tófoli, L.F.; Bogenschutz, M.P.; Hoy, R.; Berro, L.F.; Marinho, E.A.V.; Areco, K.N.; Winkelman, M.J. Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca. Front. Psychiatry 2018, 9, 136. [Google Scholar] [CrossRef] [PubMed]
- Lawn, W.; Hallak, J.E.C.; Crippa, J.A.; dos Santos, R.G.; Porffy, L.; Barratt, M.J.; Ferris, J.A.; Winstock, A.R.; Morgan, C.J. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Sci. Rep. 2017, 7, 15201. [Google Scholar] [CrossRef] [PubMed]
- Dalgalarrondo, P. Psicopatologia e Semiologia dos Transtornos Mentais, 3rd ed.; Artmed Ed: Porto Alegre, Brasil, 2000; pp. 19–866. [Google Scholar]
- da República, P.; Duarte, P.C.A.V.; Stempliuk, V.A.; Barroso, L.P. Relatório Brasileiro Sobre Drogas/Secretaria Nacional de Políticas Sobre Drogas; IME USP. SENAD: Brasília, Brasil, 2009; pp. 9–362. [Google Scholar]
- Bastos, F.I.P.M.; Vasconcellos MT, L.D.; De Boni, R.B.; Reis NB, D.; Coutinho CF, D.S. III Levantamento Nacional Sobre o uso de Drogas pela População Brasileira; FIOCRUZ/ICICT: Rio de Janeiro, Brasil, 2017; p. 528. [Google Scholar]
- Horton, D.M.; Morrison, B.; Schmidt, J. Systematized review of psychotherapeutic components of psilocybin-assisted psychotherapy. Am. J. Psychother. 2021, 74, 140–149. [Google Scholar] [CrossRef] [PubMed]
- Bogenschutz, M.P.; Podrebarac, S.K.; Duane, J.H.; Amegadzie, S.S.; Malone, T.C.; Owens, L.T.; Ross, S.; Mennenga, S.E. Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder. Front. Pharmacol. 2018, 9, 100. [Google Scholar] [CrossRef] [PubMed]
- Nielson, E.M.; May, D.G.; Forcehimes, A.A.; Bogenschutz, M.P. The psychedelic debriefing in alcohol dependence treatment: Illustrating key change phenomena through qualitative content analysis of clinical sessions. Front. Pharmacol. 2018, 9, 132. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Romeu, A.R.; Griffiths, R.; Johnson, M.W. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr. Drug Abuse Rev. 2014, 7, 157–164. [Google Scholar] [CrossRef] [PubMed]
- Noorani, T.; Garcia-Romeu, A.; Swift, T.C.; Griffiths, R.R.; Johnson, M.W. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. J. Psychopharmacol. 2018, 32, 756–769. [Google Scholar] [CrossRef] [PubMed]
- Babor, T.F.; Caetano, R. Evidence-based alcohol policy in the Americas: Strengths, weaknesses, and future challenges. Rev. Panam. Salud Pública 2005, 8, 327–337. [Google Scholar] [CrossRef] [PubMed]
- Lima, C.T.; Freire, A.C.C.; Silva, A.P.B.; Teixeira, R.M.; Farrell, M.; Prince, M. Concurrent and construct validity of the AUDIT in an urban Brazilian sample. Alcohol. Alcohol. 2005, 40, 584–589. [Google Scholar] [CrossRef] [PubMed]
- Oña, G. Elaboración y validación de un cuestionario para detección del riesgo de reacciones adversas graves por empleo de drogas psicodélicas en terapia. IJP&PT 2020, 20, 211–222. [Google Scholar]
- Dos Santos, R.G.; Osório, F.L.; Rocha, J.M.; Rossi, G.N.; Bouso, J.C.; Rodrigues, L.S.; de Oliveira Silveira, G.; Yonamine, M.; Hallak, J.E.C. Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: A pilot, proof-of-concept, randomized, placebo-controlled trial. J. Clin. Pharmacol. 2021, 41, 540–550. [Google Scholar] [CrossRef] [PubMed]
- Bardin, L. Análise de Conteúdo, 3rd ed.; Edições 70: Lisboa, Portugal, 2004; pp. 7–274. [Google Scholar]
- Perkins, D.; Opaleye, E.; Bouso, J.C.; Tófoli, L.F.; Sarris, J.; Schubert, V.; Ruffell, S.; Simonova, H. Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing. Psychoactives 2023, 2, 256–286. [Google Scholar] [CrossRef]
- Castonguay, L.G.; Hill, C.E. Insight in Psychotherapy, 1st ed.; American Psychological Association: Worcester, MA, USA, 2007; p. 448. [Google Scholar]
- Prendergast, M.L. Substance Use and Abuse among College Students: A Review of Recent Literature. J. Am. Coll. Health 1994, 43, 99–113. [Google Scholar] [CrossRef] [PubMed]
- Doering-Silveira, E.; Grob, C.S.; de Rios, M.D.; Lopez, E.; Alonso, L.K.; Tacla, C.; Da Silveira, D.X. Report on Psychoactive Drug Use among Adolescents Using Ayahuasca within a Religious Context. J. Psychoact. Drugs 2005, 37, 141–144. [Google Scholar] [CrossRef] [PubMed]
Participant | Age | Weight (kg) | AUDIT Score | Psychiatric Diagnosis | Family Income 1 | Personal Income 1 | Education | Occupation | Marital status | Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|
1 | 22 | 90 | 24 | Mild AUD | 1 to 4 minimum wages | 1 to 2 minimum wages | High school diploma | Undergraduate | Single | White |
2 | 27 | 77 | 19 | Mild MDD | 3 to 6 minimum wages | 1 to 3 minimum wages | High school diploma | Undergraduate | Single | White |
3 | 27 | 75 | 14 | - | 6 to 9 minimum wages | 1 to 4 minimum wages | Bachelor’s degree | Graduate student | Single | White |
4 | 21 | 57 | 20 | - | 3 to 6 minimum wages | 1 to 2 minimum wages | High school diploma | Undergraduate | Single | Black |
5 | 29 | 70 | 18 | - | 6 to 9 minimum wages | 1 to 3 minimum wages | Bachelor’s degree | Graduate student | Single | White |
6 | 30 | 70 | 17 | Mild AUD | 3 to 6 minimum wages | 1 to 2 minimum wages | Bachelor’s degree | Graduate student | Single | Black |
Category | Subcategories | Respondents | Category Frequency (%) |
---|---|---|---|
1. Self-perception of experience | 1.1. Uniqueness | V5 V6 | 100% |
1.2. Positive | V1 | ||
1.3. Valid | V2 | ||
1.4 Safety | V3 | ||
1.5. Switch Effect | V3 | ||
1.6. Lightness | V4 | ||
1.7. Scary, but decreased anxiety | V5 | ||
1.8. Regret during peak moments | V6 | ||
1.9. Discomfort due to a lack of control | V6 | ||
2. Positive impacts | 2.1. Decrease in anxiety | V2 V4 V5 | 83.33% |
2.2. Tranquility | V1 V4 | ||
2.3. Therapeutic effects duration | V1 V2 | ||
2.4. Lightness | V2 V3 | ||
2.5. Shift in the mental pattern | V2 V4 | ||
2.6. Increased openness to close people | V3 | ||
2.7. Self-acceptance | V4 | ||
2.8. Purification | V5 | ||
2.9. Contact with yourself | V5 | ||
3. Substance use pattern | 3.1. Alcohol—Ambivalence | V1 | 83.33% |
3.2. Decrease in alcohol intake | V2 V4 V5 | ||
3.3. Decrease in tobacco use | V4 V5 | ||
3.4. Decrease in marijuana use | V4 | ||
3.5. Unchanged | V6 | ||
4. Insights | 4.1. Significant | V1 V2 | 83.33% |
4.2. Life choices insights | V1 V6 | ||
4.3. Nonspecific | V3 V6 | ||
4.4. Happiness as an event | V2 | ||
4.5. Enjoyment of living processes | V2 | ||
4.6. Contact with anxiety × decrease in anxiety | V4 | ||
4.7. Fighting anxiety is like fighting ocean waves | V4 | ||
5. Visual effects | 5.1. Increased visual effects with closed eyes | V3 V4 V5 V6 | 66.67% |
5.2. First pleasant view | V4 | ||
5.3. Hallucinations | V4 | ||
6. Transient derealization | 6.1. Spectator feeling | V3 | 50.00% |
6.2. Loss of sense of reality | V5 | ||
6.3. Impact on spatial perception | V6 | ||
7. Sleep pattern | 7.1. Ambivalence | V4 | 33.33% |
7.2. Unchanged | V1 | ||
8. Life quality | 8.1. Unchanged | V4 | 33.33% |
8.2. Increased | V5 | ||
9. Physical symptoms | - | V4 V5 | 33.33% |
10. Synesthesia | - | V4 | 16.67% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vicentini, A.B.; Rodrigues, L.S.; Rossi, G.N.; Rocha, J.M.; Guerra, L.T.L.; Reis, J.A.S.; Maekawa, R.M.; Osório, F.d.L.; Bouso, J.C.; Santos, F.P.; et al. Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts. Psychoactives 2023, 2, 346-358. https://doi.org/10.3390/psychoactives2040022
Vicentini AB, Rodrigues LS, Rossi GN, Rocha JM, Guerra LTL, Reis JAS, Maekawa RM, Osório FdL, Bouso JC, Santos FP, et al. Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts. Psychoactives. 2023; 2(4):346-358. https://doi.org/10.3390/psychoactives2040022
Chicago/Turabian StyleVicentini, Anna Beatriz, Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, Lorena T. L. Guerra, José Augusto Silva Reis, Renan Massanobu Maekawa, Flávia de Lima Osório, José Carlos Bouso, Fabiana Pereira Santos, and et al. 2023. "Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts" Psychoactives 2, no. 4: 346-358. https://doi.org/10.3390/psychoactives2040022
APA StyleVicentini, A. B., Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Guerra, L. T. L., Reis, J. A. S., Maekawa, R. M., Osório, F. d. L., Bouso, J. C., Santos, F. P., Paranhos, B. A. P. B., Yonamine, M., Hallak, J. E. C., & dos Santos, R. G. (2023). Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts. Psychoactives, 2(4), 346-358. https://doi.org/10.3390/psychoactives2040022